Company Filing History:
Years Active: 2005
Title: Ulrike Zabel: Innovator in Medical Biotechnology
Introduction
Ulrike Zabel is a prominent inventor based in Rottendorf, Germany. She has made significant contributions to the field of medical biotechnology, particularly through her innovative research and development efforts. Her work focuses on the expression and purification of human soluble guanylyl cyclase, which has important implications for medical applications.
Latest Patents
Ulrike Zabel holds a patent for "Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1)." This invention relates to the expression of the cDNA clone for sub-units a1 (hsGCa1) and b1 (hsGCb1) of human soluble guanylyl cyclase. The patent details the purification of the active enzyme and its medical applications through gene transfer. Additionally, it includes the development of antibodies against peptides derived from the sequence, showcasing the potential for therapeutic use.
Career Highlights
Ulrike Zabel is associated with Vasopharm Biotech GmbH, where she continues to advance her research in biotechnology. Her work has been instrumental in developing new therapeutic strategies that leverage the properties of soluble guanylyl cyclase.
Collaborations
Throughout her career, Ulrike has collaborated with notable colleagues, including Harald Schmidt and Wolfgang Poller. These partnerships have enriched her research and contributed to the advancement of medical biotechnology.
Conclusion
Ulrike Zabel's innovative work in the field of medical biotechnology, particularly her patent on human soluble guanylyl cyclase, highlights her significant contributions to science and medicine. Her collaborations and career achievements continue to inspire advancements in therapeutic applications.